SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-12-000031
Filing Date
2012-05-09
Accepted
2012-05-09 15:39:34
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q quarterly_report-033112.htm 10-Q 603298
2 NEURONEX MERGER AGREEMENT exhibit10_1-neuronex.htm EX-10.1 903376
3 PAION AMENDMENT exhibit10_2-paionamendment.htm EX-10.2 30581
4 CEO CERTIFICATION exhibit31_1-ceocertification.htm EX-31.1 14866
5 CFO CERTIFICATION exhibit31_2-cfocertification.htm EX-31.2 14853
6 CEO CERTIFICATION exhibit32_1-ceocertification.htm EX-32.1 6828
7 CFO CERTIFICATION exhibit32_2-cfocertification.htm EX-32.2 6668
  Complete submission text file 0001008848-12-000031.txt   5471001

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT acor-20120331.xml EX-101.INS 451184
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acor-20120331.xsd EX-101.SCH 43850
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acor-20120331_cal.xml EX-101.CAL 54351
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acor-20120331_def.xml EX-101.DEF 227653
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acor-20120331_lab.xml EX-101.LAB 748707
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acor-20120331_pre.xml EX-101.PRE 323715
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 12825511
SIC: 2836 Biological Products, (No Diagnostic Substances)